Schrohl, Anne-Sofie <br/><br/>
Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2006 
 - 7054-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-06-0950  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anthracyclines--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Breast Neoplasms--diagnosis<br/>Cyclophosphamide--pharmacology<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fluorouracil--pharmacology<br/>Follow-Up Studies<br/>Humans<br/>Methotrexate--pharmacology<br/>Middle Aged<br/>Multivariate Analysis<br/>Predictive Value of Tests<br/>Sensitivity and Specificity<br/>Tissue Inhibitor of Metalloproteinase-1--biosynthesis<br/>Treatment Outcome